According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is A$0.13 B. In 2020 the company made a revenue of A$0.11 B an increase over the revenue in the year 2019 that were of A$81.94 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.